A Review of Effects of Atorvastatin in Radiotherapy

Radiation therapy is one of the major subsets of cancer treatments. Normal tissue toxicity and tumor cell resistance are two main obstacles during radiotherapy treatments. Toxicity to healthy tissue limits the applied dose, resulting in inadequate tumor control. On the other hand, the resistances of...

Full description

Bibliographic Details
Main Authors: Maryam Alvandi, Zahra Shaghaghi, Mohammad Reza Dehbanpour, Soghra Farzipour, Fereshteh Talebpour Amiri
Format: Article
Language:English
Published: Mazandaran University of Medical Sciences 2023-01-01
Series:Journal of Mazandaran University of Medical Sciences
Subjects:
Online Access:http://jmums.mazums.ac.ir/article-1-18168-en.pdf
_version_ 1827698683561377792
author Maryam Alvandi
Zahra Shaghaghi
Mohammad Reza Dehbanpour
Soghra Farzipour
Fereshteh Talebpour Amiri
author_facet Maryam Alvandi
Zahra Shaghaghi
Mohammad Reza Dehbanpour
Soghra Farzipour
Fereshteh Talebpour Amiri
author_sort Maryam Alvandi
collection DOAJ
description Radiation therapy is one of the major subsets of cancer treatments. Normal tissue toxicity and tumor cell resistance are two main obstacles during radiotherapy treatments. Toxicity to healthy tissue limits the applied dose, resulting in inadequate tumor control. On the other hand, the resistances of cancer cells lead to increased doses of radiotherapy. Therefore, agents that can simultaneously reduce the toxicity of normal tissues and increase the sensitivity of tumor cells to radiotherapy could be a potential solution to increase the efficiency of radiotherapy during cancer treatment. Many studies have found that atorvastatin, as an HMG coenzyme A reductase (HMG-CoA) inhibitor, and protects normal tissue while sensitizing cancer cells to radiotherapy via various molecular mechanisms and signaling pathways. This review summarizes the evidence for radioprotective and radiosensitivity effects of atorvastatin in vitro and in vivo studies.
first_indexed 2024-03-10T13:34:39Z
format Article
id doaj.art-320061cba52f4067ad6e85fa66c3de69
institution Directory Open Access Journal
issn 1735-9260
1735-9279
language English
last_indexed 2024-03-10T13:34:39Z
publishDate 2023-01-01
publisher Mazandaran University of Medical Sciences
record_format Article
series Journal of Mazandaran University of Medical Sciences
spelling doaj.art-320061cba52f4067ad6e85fa66c3de692023-11-21T07:40:17ZengMazandaran University of Medical SciencesJournal of Mazandaran University of Medical Sciences1735-92601735-92792023-01-0132217148168A Review of Effects of Atorvastatin in RadiotherapyMaryam Alvandi0Zahra Shaghaghi1Mohammad Reza Dehbanpour2Soghra Farzipour3Fereshteh Talebpour Amiri4 Associate Professor, Department of Nuclear Medicine and Molecular Imaging, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran Assistant Professor, Research Center for Molecular Medicine, Hamadan University of Medical Sciences, Hamadan, Iran BSc in Radiology, Faculty of Paramedicine, Hamadan University of Medical Sciences, Hamadan, Iran Assistant Professor, Cardiovascular Diseases Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine, Guilan University of Medical Sciences, Rasht, Iran Associate Professor, Department of Anatomy, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran Radiation therapy is one of the major subsets of cancer treatments. Normal tissue toxicity and tumor cell resistance are two main obstacles during radiotherapy treatments. Toxicity to healthy tissue limits the applied dose, resulting in inadequate tumor control. On the other hand, the resistances of cancer cells lead to increased doses of radiotherapy. Therefore, agents that can simultaneously reduce the toxicity of normal tissues and increase the sensitivity of tumor cells to radiotherapy could be a potential solution to increase the efficiency of radiotherapy during cancer treatment. Many studies have found that atorvastatin, as an HMG coenzyme A reductase (HMG-CoA) inhibitor, and protects normal tissue while sensitizing cancer cells to radiotherapy via various molecular mechanisms and signaling pathways. This review summarizes the evidence for radioprotective and radiosensitivity effects of atorvastatin in vitro and in vivo studies.http://jmums.mazums.ac.ir/article-1-18168-en.pdfatorvastatinoxidative stressradiotherapyradiosensitiveionizing radiationradioprotective
spellingShingle Maryam Alvandi
Zahra Shaghaghi
Mohammad Reza Dehbanpour
Soghra Farzipour
Fereshteh Talebpour Amiri
A Review of Effects of Atorvastatin in Radiotherapy
Journal of Mazandaran University of Medical Sciences
atorvastatin
oxidative stress
radiotherapy
radiosensitive
ionizing radiation
radioprotective
title A Review of Effects of Atorvastatin in Radiotherapy
title_full A Review of Effects of Atorvastatin in Radiotherapy
title_fullStr A Review of Effects of Atorvastatin in Radiotherapy
title_full_unstemmed A Review of Effects of Atorvastatin in Radiotherapy
title_short A Review of Effects of Atorvastatin in Radiotherapy
title_sort review of effects of atorvastatin in radiotherapy
topic atorvastatin
oxidative stress
radiotherapy
radiosensitive
ionizing radiation
radioprotective
url http://jmums.mazums.ac.ir/article-1-18168-en.pdf
work_keys_str_mv AT maryamalvandi areviewofeffectsofatorvastatininradiotherapy
AT zahrashaghaghi areviewofeffectsofatorvastatininradiotherapy
AT mohammadrezadehbanpour areviewofeffectsofatorvastatininradiotherapy
AT soghrafarzipour areviewofeffectsofatorvastatininradiotherapy
AT fereshtehtalebpouramiri areviewofeffectsofatorvastatininradiotherapy
AT maryamalvandi reviewofeffectsofatorvastatininradiotherapy
AT zahrashaghaghi reviewofeffectsofatorvastatininradiotherapy
AT mohammadrezadehbanpour reviewofeffectsofatorvastatininradiotherapy
AT soghrafarzipour reviewofeffectsofatorvastatininradiotherapy
AT fereshtehtalebpouramiri reviewofeffectsofatorvastatininradiotherapy